RPG Life Sciences
 | |
| Company type | Public |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1993 |
| Headquarters | Mumbai, Maharashtra, India |
Key people | Yugal Sikri (Managing Director)[1] |
| Revenue | ₹512.81 crore (US$61 million) (2023)[2] |
| Parent | RPG Enterprises |
| Website | www.rpglifesciences.com |
RPG Life Sciences (RPGLS) is an Indian pharmaceutical company. Formerly known as Searle (India) Ltd, RPG Life Sciences is part of RPG Enterprises.[3] It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as API (active pharmaceutical ingredients); pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries.[4]
References
[edit]- ^ "RPG Life Sciences formulates growth plan". The Hindu Business Line. 13 July 2010. Retrieved 28 September 2010.
- ^ "RPG Life Sciences – Audited Financial Result 2022–2023".
- ^ "RPG Life Sciences eyes private equity placement". Hindustan Times. 27 July 2009. Archived from the original on 25 January 2013. Retrieved 28 September 2010.
- ^ [1] Archived 30 June 2007 at the Wayback Machine
External links
[edit]
